Foundation Care News Release
Foundation Care Pharmacy, located in Earth City, MO, will be one of the pharmacies to provide cystic fibrosis patients with the new Vertex drug KALYDECO™ (ivacaftor). KALYDECO (kuh-LYE-deh-koh) is approved for people with CF ages 6 and older who have at least one copy of the G551D mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. It is the first treatment to target the underlying cause of CF.
Cystic Fibrosis is an inherited chronic disease that affects the lungs and digestive system of about 30,000 children and adults in the United States (70,000 worldwide). CF is caused by defective or missing cystic fibrosis transmembrane conductance regulator (CFTR) proteins resulting from mutations in the CFTR gene.
KALYDECO is for adults and pediatric patients age 6 years and older: and administered one 150 mg tablet taken orally every 12 hours with fat-containing food. It has been approved to treat people with at least one copy of the G551D mutation, the most common gating defect representing approximately 4 percent of those with CF, or about 1,200 people in the United States.
Foundation Care opened its doors in 2004 as a full service retail pharmacy with a specialty in treating cystic fibrosis. Since then, their pharmacists and staff have become extremely knowledgeable in the treatment of CF. Also, their relationships with caregivers, physicians, and insurance providers across the nation ensure that each patient receives the expertise and guidance needed in today’s complex healthcare world.
Over the years, Foundation Care has constantly strived to find new ways to make a patient’s treatment easier and more affordable. “Being a provider of KALYDECO is very exciting for Foundation Care. We are now able to offer our physicians and patients another treatment alternative for cystic fibrosis.” Daniel Blakeley, RPh, Owner and Chief Executive Officer of Foundation Care.
About Foundation Care
Foundation Care LLC is a full service pharmacy serving patients nationwide. Located in Saint Louis, MO, Foundation Care provides retail prescription needs, as well as specialty care to patients challenged by rare, chronic illnesses, such as Bronchiectasis, Cystic Fibrosis, and Diabetes. Foundation Care continues to provide the most up-to-date medications while working to make our patients treatment easier and more affordable. For additional information, visit www.FoundCare.com or call Foundation Care at (314) 291-1122 or toll-free at (877) 291-1122.